Avonex® (interferon beta - 1a) – PRODUCT INFORMATION

AVONEX is approved by the FDA to treat relapsing forms of multiple sclerosis (MS), to decrease the number of flare-ups and to slow the occurrence of some of the disability that is common in people with MS.

For more information, please visit Avonex.com or download the full prescribing information.

Avonex is a registered trademark of Biogen Idec. Avonex Direct Delivery is a service mark of Biogen Idec.